SCHEMBL16697977

SCHEMBL16697977

c1cnc2c(c1)cc(-c1ccc3oc4ccc(-c5cc6cccnc6c6ncccc56)cc4c3c1)c1cccnc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 5/20 0.49
CCR8 P51685 5/20 0.49
L3MBTL1 Q9Y468 4/20 0.49
MAPT P10636 3/20 0.43
ALDH1A1 P00352 2/20 0.43
PDE4D Q08499 7/20 0.41
PIK3CD O00329 1/20 0.40
CCR5 P51681 3/20 0.40
HSP90AA1 P07900 2/20 0.40
LMNA P02545 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GMNN O75496 1/20 0.40
TP53 P04637 1/20 0.40
MMP2 P08253 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
MMP9 P14780 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31285974 1.00 CCR1 (0.49) CCR1CCR8L3MBTL1MAPTALDH1A1
SCHEMBL23331492 0.96 MAPT (0.46) CCR1CCR8L3MBTL1MAPTALDH1A1
SCHEMBL21512244 0.90 CCR1 (0.40) CCR1CCR8L3MBTL1MAPTALDH1A1
SCHEMBL15582325 0.89 MAPT (0.43) CCR1CCR8L3MBTL1MAPTALDH1A1
SCHEMBL20726665 0.89 MAPT (0.40) CCR1CCR8L3MBTL1MAPTALDH1A1
SCHEMBL20726663 0.88 MAPT (0.42) CCR1CCR8L3MBTL1MAPTALDH1A1
SCHEMBL21512230 0.88 PDE4D (0.39) CCR1CCR8L3MBTL1MAPTALDH1A1
SCHEMBL21396190 0.88 PGR (0.40) CCR1CCR8L3MBTL1MAPTALDH1A1
SCHEMBL21395909 0.88 PGR (0.40) CCR1CCR8L3MBTL1MAPTALDH1A1
SCHEMBL21261456 0.88 CCR1 (0.43) CCR1CCR8L3MBTL1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11700768-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-07-11 US disclosed
US-11700768-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-07-11 US disclosed
EP-3556750-B1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING SAME LG CHEMICAL LTD (KR) 2021-02-24 EP disclosed
EP-3556750-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING SAME LG Chem, Ltd. (KR) 2019-10-23 EP disclosed
US-9917261-B2 Organic compound, light-emitting element, display module, lighting module, light-emitting device, display device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-03-13 US disclosed
US-9917261-B2 Organic compound, light-emitting element, display module, lighting module, light-emitting device, display device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-03-13 US disclosed
US-9917261-B2 Organic compound, light-emitting element, display module, lighting module, light-emitting device, display device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-03-13 US disclosed
US-20150131302-A1 Organic Compound, Light-Emitting Element, Display Module, Lighting Module, Light-Emitting Device, Display Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2015-05-14 US disclosed
US-20150131302-A1 Organic Compound, Light-Emitting Element, Display Module, Lighting Module, Light-Emitting Device, Display Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2015-05-14 US disclosed
US-20150131302-A1 Organic Compound, Light-Emitting Element, Display Module, Lighting Module, Light-Emitting Device, Display Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2015-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11700768-B2 Compound and organic light emitting device comprising the same ARL1, ARRB1, CRY1 CCR1 591/4885CCR8 2573/4885L3MBTL1 1376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.